AMBRISENTAN Side Effects

7013567-4 | Right Ventricular Failure
on Sep 13, 2010 Male patient from GREECE , 65 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: right ventricular failure. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

7013566-2 | Pneumonia, Sepsis
Patient was taking Ambrisentan (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), sepsis (What is sepsis?) on Sep 14, 2010 from GREECE Additional patient health information: Male patient , 75 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Ambrisentan dosage: 5mg Per Day. Patient was hospitalized.

6963941-7 | Right Ventricular Failure
Adverse event was reported on Aug 16, 2010 by a Male patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with pulmonary arterial hypertension, infarction, hernia (What is hernia?), myocardial infarction and. Location: FRANCE , weighting 147.7 lb, After Ambrisentan was administered, patient had the following side effects: right ventricular failure. During the same period patient was treated with TREPROSTINIL (45ukm Continuous) (View Treprostinil Review and Treprostinil Label ), KARDEGIC (75mg Per Day) (View Kardegic Review and Kardegic Label ), SILDENAFIL (20mg Three Times Per Day) (View Sildenafil Review and Sildenafil Label ), NEXIUM (20mg Single Dose) (View Nexium Review and Nexium Label ), TAHOR (40mg Per Day) (View Tahor Review and Tahor Label ), LASIX (40mg Per Day) (View Lasix Review and Lasix Label ), AMAREL (4mg Per Day) (View Amarel Review and Amarel Label ). Patient was hospitalized.

6943471-9 | Localised Oedema, Renal Impairment
on Aug 12, 2010 Male patient from NETHERLANDS , weighting 216.1 lb, was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?) and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: localised oedema, renal impairment. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with SILDENAFIL (60mg Per Day) (View Sildenafil Review and Sildenafil Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), HUMALOG (View Humalog Review and Humalog Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ETALPHA (View Etalpha Review and Etalpha Label ). Patient was hospitalized.


6934567-6 | Hepatitis
on Aug 17, 2010 Male patient from UNITED KINGDOM , weighting 163.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Ambrisentan dosage: . During the same period patient was treated with TREPROSTINIL (View Treprostinil Review and Treprostinil Label ), WARFARIN (View Warfarin Review and Warfarin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6925889-3 | Renal Failure Acute
Patient was taking Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: renal failure acute on Aug 03, 2010 from GERMANY Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with pulmonary arterial hypertension, respiratory failure, cardiac failure, diarrhoea and. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with FORADIL (View Foradil Review and Foradil Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), PERENTEROL (250mg Twice Per Day) (View Perenterol Review and Perenterol Label ). Patient was hospitalized.

6917625-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatotoxicity, Hypertransaminasaemia
Adverse event was reported on Jul 30, 2010 by a Female patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), sclerodactylia and. Location: SPAIN , 59 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatotoxicity, hypertransaminasaemia. During the same period patient was treated with BOSENTAN (View Bosentan Review and Bosentan Label ), PREDNISONE (5mg Per Day) (View Prednisone Review and Prednisone Label ).

6915073-1 | Blood Creatinine Increased, Fluid Retention
on Jul 28, 2010 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient had the following side effects: blood creatinine increased, fluid retention. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with SILDENAFIL CITRATE (50mg Three Times Per Day) (View Sildenafil Citrate Review and Sildenafil Citrate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ADCAL D3 (View Adcal D3 Review and Adcal D3 Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6910751-2 | Idiopathic Pulmonary Fibrosis, Sepsis
on Jul 26, 2010 Male patient from UNITED STATES , weighting 226.9 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: idiopathic pulmonary fibrosis, sepsis (What is sepsis?). Ambrisentan dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized and became disabled.

6906930-0 | Pneumonitis
Patient was taking Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 277.3 lb, was diagnosed with idiopathic pulmonary fibrosis, hypertension, gastrooesophageal reflux prophylaxis, pain (What is pain?), psoriasis and. Ambrisentan dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OXYGEN (View Oxygen Review and Oxygen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PERCOCET (View Percocet Review and Percocet Label ), ENBREL (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

6896664-3 | Cardiac Failure, Fluid Retention, Weight Increased
Adverse event was reported on Jul 23, 2010 by a Female patient taking Ambrisentan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: FRANCE , 67 years of age, weighting 220.5 lb, Patient had the following side effects: cardiac failure, fluid retention, weight increased. Patient was hospitalized.

6884836-3 | Idiopathic Pulmonary Fibrosis, Sepsis
on Jul 26, 2010 Male patient from UNITED STATES , weighting 226.6 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: idiopathic pulmonary fibrosis, sepsis (What is sepsis?). Ambrisentan dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6880982-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatotoxicity, Hypertransaminasaemia, Transaminases Increased
on Jul 19, 2010 Female patient from SPAIN , 59 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), sclerodactylia and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatotoxicity, hypertransaminasaemia, transaminases increased. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with BOSENTAN (View Bosentan Review and Bosentan Label ), PREDNISONE (5mg Per Day) (View Prednisone Review and Prednisone Label ).

6880873-3 | Oedema Peripheral, Purpura
Patient was taking Ambrisentan (View Usage). Patient had the following side effects: oedema peripheral, purpura on Jul 13, 2010 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with pulmonary arterial hypertension and. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), AMAREL (View Amarel Review and Amarel Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LERCAN (View Lercan Review and Lercan Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6876784-X | Migraine
Adverse event was reported on Jun 10, 2010 by a Male patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?), sleep disorder (What is sleep disorder?) and. Location: NETHERLANDS , weighting 266.8 lb, After Ambrisentan was administered, patient had the following side effects: migraine (What is migraine?). During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), DORMICUM (7.5mg Per Day) (View Dormicum Review and Dormicum Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ).

6785089-7 | Respiratory Failure
on Jun 09, 2010 Female patient from GREECE , 70 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory failure. Ambrisentan dosage: 5mg Per Day. Patient was hospitalized.

6785077-0 | Anxiety, Hypomania, Insomnia, Pressure Of Speech
on Jun 07, 2010 Female patient from AUSTRALIA , weighting 160.5 lb, was treated with Ambrisentan (View Usage). Patient had the following side effects: anxiety (What is anxiety?), hypomania, insomnia, pressure of speech. Ambrisentan dosage: 2.5mg Per Day. During the same period patient was treated with FRUSEMIDE (View Frusemide Review and Frusemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6780126-8 | Cardiac Failure Chronic, Renal Failure
Patient was taking Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: cardiac failure chronic, renal failure on Jun 08, 2010 from GREECE Additional patient health information: Male patient , 55 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with SILDENAFIL (20mg Three Times Per Day) (View Sildenafil Review and Sildenafil Label ). Patient was hospitalized.

6780122-0 | Respiratory Failure
Adverse event was reported on Jun 08, 2010 by a Female patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: GREECE , 85 years of age, Patient experienced the following unwanted or unexpected effects: respiratory failure.

6762542-3 | Pneumonitis
on Jun 02, 2010 Male patient from UNITED STATES , weighting 277.3 lb, was diagnosed with idiopathic pulmonary fibrosis, hypertension, gastrooesophageal reflux prophylaxis, pain (What is pain?), psoriasis and was treated with Ambrisentan (View Usage). Patient had the following side effects: pneumonitis. Ambrisentan dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OXYGEN (View Oxygen Review and Oxygen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PERCOCET (View Percocet Review and Percocet Label ), ENBREL (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

6744691-9 | Pneumonitis
on May 21, 2010 Male patient from UNITED STATES , weighting 277.3 lb, was diagnosed with idiopathic pulmonary fibrosis, hypertension, gastrooesophageal reflux prophylaxis, pain (What is pain?), psoriasis and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: pneumonitis. Ambrisentan dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OXYGEN (View Oxygen Review and Oxygen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PERCOCET (View Percocet Review and Percocet Label ), ENBREL (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

6734556-0 | Pneumonitis
Patient was taking Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis on May 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 277.3 lb, was diagnosed with idiopathic pulmonary fibrosis and. Ambrisentan dosage: . Patient was hospitalized.

6728692-2 | Pulmonary Hypertension, Right Ventricular Failure
Adverse event was reported on May 06, 2010 by a Male patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure and. Location: GREECE , 65 years of age, Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PREZOLON (15mg Per Day) (View Prezolon Review and Prezolon Label ).

6720277-7 | Asthenia, Dyspnoea, Fatigue, Muscular Weakness
on Apr 29, 2010 Male patient from SPAIN , 45 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: asthenia, dyspnoea, fatigue, muscular weakness. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), AMLODIPINO (View Amlodipino Review and Amlodipino Label ), SUTRIL (View Sutril Review and Sutril Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6714513-0 | Hypertensive Encephalopathy, Pulmonary Arterial Hypertension
on Apr 26, 2010 Female patient from BRAZIL , weighting 123.5 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive encephalopathy, pulmonary arterial hypertension. Ambrisentan dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ). Patient was hospitalized.

6714198-3 | Arrhythmia, Cardiac Failure, Ejection Fraction, Pulmonary Oedema
Patient was taking Ambrisentan (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), cardiac failure, ejection fraction, pulmonary oedema on Apr 26, 2010 from GREECE Additional patient health information: Male patient , 67 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6712390-5 | Cardiac Failure, Hepatosplenomegaly, Oedema, Weight Increased
Adverse event was reported on Apr 23, 2010 by a Female patient taking Ambrisentan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension, diabetes mellitus and. Location: GERMANY , weighting 160.9 lb, After Ambrisentan was administered, patient had the following side effects: cardiac failure, hepatosplenomegaly, oedema, weight increased. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), FALITHROM (View Falithrom Review and Falithrom Label ), ALISKIREN (View Aliskiren Review and Aliskiren Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6712383-8 | Multi-organ Failure
on Apr 23, 2010 Male patient from GERMANY , 64 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure. Ambrisentan dosage: 10mg Per Day. During the same period patient was treated with SILDENAFIL (View Sildenafil Review and Sildenafil Label ).

6703025-6 | Haemoptysis
on Apr 23, 2010 Male patient from UNITED STATES , weighting 200.2 lb, was diagnosed with idiopathic pulmonary fibrosis, prophylaxis, diabetes mellitus, hypercholesterolaemia, hypertension and was treated with Ambrisentan (View Usage). Patient had the following side effects: haemoptysis. Ambrisentan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LANTUS (View Lantus Review and Lantus Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6702955-9 | Pneumonitis
Patient was taking Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: pneumonitis on Apr 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 277.3 lb, was diagnosed with idiopathic pulmonary fibrosis and. Ambrisentan dosage: . Patient was hospitalized.

6699213-8 | Hypoxia, Pleural Effusion, Respiratory Disorder
Adverse event was reported on Apr 15, 2010 by a Female patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with venoocclusive disease, pulmonary arterial hypertension and. Location: GERMANY , weighting 169.8 lb, Patient experienced the following unwanted or unexpected effects: hypoxia, pleural effusion, respiratory disorder. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), ILOPROST (View Iloprost Review and Iloprost Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), PENTAERYTHRITOL TETRANITRATE (View Pentaerythritol Tetranitrate Review and Pentaerythritol Tetranitrate Label ). Patient was hospitalized.

6694289-6 | Pneumonitis
on Apr 12, 2010 Male patient from UNITED STATES , weighting 277.3 lb, was diagnosed with idiopathic pulmonary fibrosis and was treated with Ambrisentan (View Usage). Patient had the following side effects: pneumonitis. Ambrisentan dosage: . Patient was hospitalized.

6692728-8 | Haemoptysis
on Apr 15, 2010 Male patient from UNITED STATES , weighting 200.2 lb, was diagnosed with idiopathic pulmonary fibrosis, prophylaxis, diabetes mellitus, hypercholesterolaemia, hypertension and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: haemoptysis. Ambrisentan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LANTUS (View Lantus Review and Lantus Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6689425-1 | Multi-organ Failure
Patient was taking Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure on Apr 12, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, was diagnosed with pulmonary arterial hypertension and. Ambrisentan dosage: 10mg Per Day. During the same period patient was treated with SILDENAFIL (View Sildenafil Review and Sildenafil Label ).

6683556-8 | Haemoptysis
Adverse event was reported on Apr 09, 2010 by a Male patient taking Ambrisentan (View Usage) (Dosage: ) was diagnosed with idiopathic pulmonary fibrosis, prophylaxis, diabetes mellitus, hypercholesterolaemia, hypertension and. Location: UNITED STATES , weighting 200.2 lb, Patient had the following side effects: haemoptysis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LANTUS (View Lantus Review and Lantus Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6673548-7 | Haemoptysis
on Mar 30, 2010 Male patient from UNITED STATES , weighting 200.2 lb, was diagnosed with idiopathic pulmonary fibrosis, prophylaxis, diabetes mellitus, hypercholesterolaemia, hypertension and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: haemoptysis. Ambrisentan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LANTUS (View Lantus Review and Lantus Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6664490-6 | Migraine
on Mar 25, 2010 Male patient from NETHERLANDS , weighting 266.8 lb, was diagnosed with pulmonary arterial hypertension, pulmonary hypertension (What is pulmonary hypertension?), sleep disorder (What is sleep disorder?) and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?). Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), DORMICUM (7.5mg Per Day) (View Dormicum Review and Dormicum Label ).

6659948-X | Haemoptysis
Patient was taking Ambrisentan (View Usage). Patient had the following side effects: haemoptysis on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.2 lb, was diagnosed with idiopathic pulmonary fibrosis and. Ambrisentan dosage: .

6659808-4 | Hepatitis
Adverse event was reported on Mar 17, 2010 by a Male patient taking Ambrisentan (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED KINGDOM , weighting 163.1 lb, After Ambrisentan was administered, patient had the following side effects: hepatitis (What is hepatitis?). During the same period patient was treated with TREPROSTINIL (View Treprostinil Review and Treprostinil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6643479-7 | Hypotension, Pulmonary Arterial Hypertension
on Mar 04, 2010 Female patient from BRAZIL , weighting 123.5 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, pulmonary arterial hypertension. Ambrisentan dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ). Patient was hospitalized.

6621825-8 | Oedema Peripheral, Purpura
on Feb 25, 2010 Male patient from FRANCE , 67 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient had the following side effects: oedema peripheral, purpura. Ambrisentan dosage: 5mg Per Day. Patient was hospitalized.

6621744-7 | Atrial Flutter, Coronary Arterial Stent Insertion, Oedema
Patient was taking Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: atrial flutter, coronary arterial stent insertion, oedema on Feb 25, 2010 from GERMANY Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with pulmonary arterial hypertension and. Ambrisentan dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6614154-X | Angina Unstable, Haemoglobin Decreased, Haemoptysis
Adverse event was reported on Feb 22, 2010 by a Male patient taking Ambrisentan (View Usage) (Dosage: ) was diagnosed with idiopathic pulmonary fibrosis and. Location: UNITED STATES , weighting 200.2 lb, Patient experienced the following unwanted or unexpected effects: angina unstable, haemoglobin decreased, haemoptysis.

6606565-3 | Atrial Fibrillation, Chest Discomfort, Chronic Obstructive Pulmonary Disease, Dehydration, Diarrhoea, Dyspnoea Exertional, Emphysema, Hilar Lymphadenopathy
on Feb 16, 2010 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with pulmonary arterial hypertension, thrombosis prophylaxis, respiratory failure and was treated with Ambrisentan (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), chest discomfort, chronic obstructive pulmonary disease, dehydration, diarrhoea, dyspnoea exertional, emphysema, hilar lymphadenopathy. Ambrisentan dosage: . During the same period patient was treated with SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6583920-1 | Hypotension
on Feb 05, 2010 Female patient from SPAIN , 48 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: hypotension. Ambrisentan dosage: . Patient was hospitalized.

6578093-5 | Pleural Effusion
Patient was taking Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion on Feb 01, 2010 from GERMANY Additional patient health information: Female patient , 45 years of age, weighting 169.8 lb, was diagnosed with venoocclusive disease and. Ambrisentan dosage: 5mg Per Day. During the same period patient was treated with SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), ILOPROST (View Iloprost Review and Iloprost Label ). Patient was hospitalized.

6574353-2 | Pulmonary Fibrosis, Pulmonary Hypertension
Adverse event was reported on Jan 28, 2010 by a Female patient taking Ambrisentan (View Usage) (Dosage: 5mg Per Day) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: GREECE , 78 years of age, Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?), pulmonary hypertension (What is pulmonary hypertension?).

6541477-5 | Angina Unstable
on Jan 06, 2010 Male patient from UNITED STATES , weighting 201.2 lb, was diagnosed with idiopathic pulmonary fibrosis, hypercholesterolaemia, prophylaxis, hypertension, diabetes mellitus, back pain (What is back pain?) and was treated with Ambrisentan (View Usage). After Ambrisentan was administered, patient had the following side effects: angina unstable. Ambrisentan dosage: . During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LANTUS (View Lantus Review and Lantus Label ), VICODIN (View Vicodin Review and Vicodin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6525766-6 | Hepatitis
on Dec 23, 2009 Male patient from UNITED KINGDOM , weighting 163.1 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Ambrisentan dosage: . During the same period patient was treated with TREPROSTINIL (View Treprostinil Review and Treprostinil Label ), WARFARIN (View Warfarin Review and Warfarin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6509119-2 | Angioedema, Bronchospasm, Dyspnoea, Flushing, Rhinitis
Patient was taking Ambrisentan (View Usage). Patient had the following side effects: angioedema, bronchospasm, dyspnoea, flushing, rhinitis on Dec 10, 2009 from GERMANY Additional patient health information: Female patient , weighting 178.6 lb, was diagnosed with pulmonary arterial hypertension and. Ambrisentan dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).